ATRX and astrocytoma (excluding glioblastoma): However, not all IDH-mutant astrocytomas show ATRX and/or TP53 mutations, and not all mutations are clearly detectable by surrogate immunohistochemical stains; therefore, further molecular testing may be necessary in a limited number of cases.